| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;35:952.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Physiology (S.B.H., A.K.), The University of Melbourne, Parkville, Victoria, Australia; the MRC Blood Pressure Unit (R.F., A.F.L.) and the Department of Medicine & Therapeutics (D.L.D.), Western Infirmary, Glasgow, UK; the Department of Medicine (A.D.C.), Royal Infirmary, Edinburgh, UK; the Northern Regional Health Authority (C.J.W.F.), Newcastle upon Tyne, UK; Duncan Guthrie Institute of Medical Genetics (J.M.C.), Yorkhill, Glasgow, UK; and the Department of Public Health (G.C.M.W.), University of Glasgow, Glasgow, UK.
| Abstract |
|---|
|
|
|---|
Key Words: electrolytes family history genetics renal function renin
| Introduction |
|---|
|
|
|---|
In humans, borderline hypertension or a family history of hypertension has been associated with high or normal GFR and low or normal RBF.7 8 9 10 11 12 Few data exist in relation to extracellular fluids, but 1 study has suggested that exchangeable sodium is reduced in young hypertensive subjects.13 Animal models of genetic hypertension show renal phenotypic abnormalities during the development of hypertension, but their exact nature depends on the specific strain. In young spontaneously hypertensive rats14 and Dahl salt-sensitive rats,15 low GFR and RBF are seen during the development of hypertension. In contrast, young Milan hypertensive rats16 and fawn-hooded rats17 exhibit increased GFR compared with control rats.
The aim of the present study was to examine renal function and hemodynamics, extracellular sodium and fluid volumes, and plasma active renin in healthy young adults with contrasting predispositions to high BP.
| Methods |
|---|
|
|
|---|
Offspring personal BPs were plotted against their combined parental
pressures in a scatter diagram.20 For the purposes of this
analysis and consistent with our previous methods, high
BPs were considered to be those in approximately the top 30% of age-
and gender-specific parental and offspring BP distributions. Low
pressures were those in the bottom 30% of the distributions. The
different combinations of high and low personal and parental BPs in
each corner of the scatter diagram resulted in 4 parent and offspring
combinations constituting offspring with high personal and low parental
BPs, high personal and high parental BPs, low personal and low parental
BPs, and low personal and high parental BPs. In the original selection
of 864 offspring, these groups were composed of 122, 118, 163, and 68
individuals, respectively.18 The definition of high BP
used in the present study meant that the group with high personal
and high parental BP was representative of
14% of
the general population. When considered according to personal and
parental BPs, this group constituted approximately one third of the
young adults with high BP and about one half of the offspring with high
parental BPs. For the present study, a contact list was compiled of
200 offspring, composed of 50 subjects chosen at random from the 4
original groups. This list did not reveal group allocations. One
investigator (S.B.H.) recruited 100 offspring from this list. After the
clinical experiments, it was revealed that there were
25 offspring
from each group.
Clinical Protocol
Subjects were admitted to the hospital overnight on their normal
diet. To minimize potential bias or perturbation of
physiological traits,21 the BP
categorization of the parents and the offspring was not revealed to
either the participants or the clinical investigators. To minimize
variation related to the menstrual cycle, all females were asked to
attend within 10 days of their last menstrual period. Informed consent
was obtained from all subjects, and the studies were approved by the
Western Infirmary Ethics Committee.
On admission, the height and weight of participants were measured. Measurements of subcutaneous fat were used to calculate total body fat and lean body mass. All subjects were given a solution containing 24Na and 3H for body sodium and water estimation. To measure isotope and electrolyte excretion, urine was collected from the time of isotope administration until the time of blood sampling 20 hours later. Other than water, all subjects were fasted from 9 PM on the first day.
The following morning, subjects were prepared for investigation, and intravenous cannulas were inserted into the right and left cubital veins. A BP cuff was attached to the right arm, and BP and pulse rate were measured automatically by a Copal UA251 Auto-Inflation Digital Sphygmomanometer (Takeda Medical Corp) while subjects remained semisupine in bed. Three readings were taken every half hour and were averaged to calculate the systolic and diastolic BPs and pulse rate. Mean arterial pressure was calculated as diastolic BP plus one third of the difference between systolic and diastolic BPs.
Electrolytes and Renal Function
These methods have been described in detail
elsewhere.22 Total exchangeable sodium and body water were
estimated from dilution of 24Na and
3H given earlier. Plasma volume was estimated
from the dilution of an injected bolus of
125I-labeled albumin.22
GFR and renal plasma flow were measured by using constant infusions of inulin (50 g/50 mL, Laevosan-Gesellschaft MBH) and p-aminohippurate (PAH, 2 g/10 mL, MSD), respectively. A loading dose of inulin (30 g/70 kg) and PAH (0.8 g/70 kg) was given, half as a rapid bolus injection and the rest over 10 minutes, and a constant infusion of inulin (0.96 g/h) and PAH (0.48 g/h) was begun. To ensure stable levels, clearance measurements were not begun until 2 hours later. Each subject was given 5 mL/kg of water to drink at the time of the loading bolus, followed by 1 mL/kg every half hour. Four consecutive half-hour estimates of GFR and effective renal plasma flow (ERPF) were made. RBF was calculated from ERPF and the hematocrit, and RVR was calculated from the RBF and mean arterial pressure. The concentration of urinary albumin was measured in a sample of urine collected during the first 2 hours of inulin and PAH infusion.
Biochemical Phenotypes
Just before the initiation of renal function studies, blood
samples were taken for plasma active renin and aldosterone
concentrations, which were measured according to previously published
methods.18 These samples were also used for determination
of total body water and exchangeable sodium and plasma volume. At the
time of discharge, all participants were given a container and asked to
complete a 24-hour urine collection for measurement of electrolytes,
creatinine, prostaglandins,23 and
total kallikrein.24
Genotypes
DNA was extracted from whole blood and purified as described
previously,18 and polymorphic variants of relevant
genes were determined for each person to test for associations between
genotypes and GFR and plasma active renin. The following
polymorphisms were determined: renin gene (HindIII and
BglI restriction fragment length
polymorphisms),25
angiotensin-converting enzyme (ACE) gene
(insertion/deletion polymorphism),26 and
angiotensinogen gene (M235T
polymorphism).27
Statistical Analysis
Data are summarized as means with 95% CIs except where stated.
Urinary kallikrein and prostaglandin data underwent
logarithmic transformations before parametric analyses.
The effects of categorization according to high or low parental and
personal BPs were analyzed by using a 2x2 factorial ANOVA
design. Regression analysis was used to examine relations
between variables in the combined group of 100 subjects. To control
for any gender-related differences in ANOVA and regression
analyses, gender was also entered as a dummy variable
(female 0, male 1). The
2 test was used to
compare gender distribution and the use of the oral contraception
between groups. The effects of genotype were assessed by 1-way
ANOVA. In view of the number of comparisons, statistical significance
was accepted as P<0.02.
| Results |
|---|
|
|
|---|
2 2.31, df 3, P=0.51)
and use of the oral contraceptive pill (
2
6.35, df 3, P=0.10) did not differ between
groups. The mean systolic and diastolic BPs of the
4 groups (Table 1) were consistent with the original
categorization that had been defined by BP measurements 3 years before
the present study.18 This consistency
demonstrates the continued robustness of the original sampling
criteria. High BP in offspring was associated with significantly higher
body weight and body fat (Table 1). Body mass index showed a
similar pattern (data not shown).
|
Exchangeable Sodium, Body Fluid Volumes, and Plasma Active
Renin
Exchangeable sodium and plasma volume were significantly lower in
offspring with high BP (Table 2).
There were no significant differences in total body water (data not
shown).
|
Plasma active renin was significantly higher in offspring with high BP (Table 2). The highest average plasma active renin was seen in offspring with high personal and parental pressures. Plasma active renin correlated significantly (r=-0.26, P<0.006) with plasma volume. No significant differences in plasma aldosterone or the daily urinary excretion of sodium or potassium were detected between the groups (data not shown).
Average values for 24-hour urinary excretion of kallikrein were not
different between the groups (Table 2). The daily excretion of
6-ketoprostaglandin F1
and
prostaglandin E2 did not differ
according to either parental or personal BP groupings (data not
shown).
Renal Function and Hemodynamics
The highest average GFR was observed in offspring from families in
which both parents had high BP (Table 2; P=0.02,
1-way ANOVA). With use of a factorial analysis, a significant
effect of parental pressure on GFR was found (Table 2,
P=0.02). However, this effect was most striking for subjects
with high personal BP, in whom the difference associated with high
parental BP was 19 mL/min per 1.73 m2, compared
with only a 3 mL/min per 1.73 m2 difference in
subjects with low personal BP (Table 2).
Urinary albumin concentrations were below detectable limits (<5 mg/L) in 89 of the 100 subjects. Average levels of GFR were not different in subjects with (125.5±22.2 mL/min per 1.73 m2) or without (125.6±24.7 mL/min per 1.73 m2) detectable urinary albumin (5 to 22 mg/L). Detectable albumin was not associated with high parental or personal BPs.
No significant differences in ERPF (Table 2) or RBF (data not shown) were observed between the groups. The RVR was significantly higher in offspring with high BP (P=0.02), irrespective of parental BP (Table 2). We observed a significant relation between plasma active renin and both GFR (r=0.22, P=0.02) and filtration fraction (r=0.20, P=0.02). A significant inverse correlation also existed between GFR and exchangeable sodium (r=-0.26, P=0.01).
Genotypes
The summary data of phenotypes in relation to
genotypes are shown in Table 3. No significant differences were
observed in plasma active renin or GFR for genotypes of the
renin, ACE, or angiotensinogen genes.
|
| Discussion |
|---|
|
|
|---|
Two special features of the research design deserve comment. First, the definition of high and low BP equates to pressures in the upper and lower thirds of the age and gender distributions, respectively. Therefore, our findings are relevant and explain why large numbers of people have BPs above and below the population mean rather than why a few people have pressures in the upper tail of the distribution. The epidemiological significance is that most of the cardiovascular events that are attributable to raised BP occur in the large numbers of people at moderate risk rather than the small number of people at high risk.28 29
Second, predisposition to hypertension was defined in terms of personal and parental pressures.19 20 As a consequence of tracking, high personal pressures in youth predispose one to high pressures throughout adulthood. High parental pressure predisposes offspring as a result of familial aggregation. The 4 combinations of high and low personal and parental pressures afford special opportunities to examine familial and nonfamilial correlates of high BP. The approach provides information that might be diluted in studies that use either personal pressure (eg, "borderline" hypertension) or parental (eg, "family history" of hypertension) pressure alone to define BP predisposition.
Despite the broad definitions of high BP in the present study, the findings are consistent with observations in established clinical hypertension. In particular, the reduced plasma volume and exchangeable sodium observed in young adults with high BP mirrors findings in hypertensive subjects.4 5 6 30 31 The congruity between high pressure and low fluid extracellular volumes suggests that volume depletion is a consequence of high BP, even from the earliest phases, when BP differences are relatively small.
In the present study and also in studies of hypertensive subjects, lower exchangeable sodium and extracellular fluid volumes might reflect the differences in body composition associated with high BP. Young adults with high BP in the present study were, on average, 7 kg heavier than those with low BP. About half of this difference was accountable by differences in body fat, which is relatively free of extracellular fluid. Therefore, some (but not all) of the findings of low exchangeable sodium and extracellular fluid volume are attributable to increased fat mass.
We observed a qualitatively different relation between plasma renin and BP in subjects in the present study compared with subjects with essential hypertension. In hypertension, as in the normal population, higher BP is associated with lower plasma renin.32 However, high BP in young adults in the present study was associated with significantly higher plasma active renin. High renin in young people predisposed to hypertension has been reported in many,10 33 34 35 36 37 38 but not all,8 11 39 40 published studies.
Our findings suggest that the normal baroreceptor-mediated suppression of renin by high BP41 is perturbed in the early development of high BP. Sympathetic renal nerve activity may be an important stimulus to renin release in high BP.42 43 44 We have demonstrated previously evidence of increased activity of the sympathetic nervous system associated with high BP in our population.45 As hypertension develops, renin levels become suppressed, partly because of higher arterial pressures but also as a result of increased central blood volume.46
We observed glomerular hyperfiltration in young people with high personal and parental BPs. High GFR is not a feature of established hypertension, nor is it a feature of high BP per se in the present study, being absent in young people with high BPs who have parents with low BPs. Our observations are consistent with 2 previous studies of normotensive subjects with a family history of hypertension.7 12 These findings contrast with other studies reporting normal GFR in subjects predisposed to hypertension.8 11 47 48 49 The reasons for the discrepancies are not immediately obvious, but the studies differ substantially in the populations examined, the definition of predisposition, the age of subjects, and the methods of measuring GFR. The inulin clearance method used in the present study is one of the most reliable available.
The observed correlation between plasma renin with GFR and filtration
fraction suggests a link between the 2 phenotypes. This may
result from angiotensin-dependent preferential
vasoconstriction of the postglomerular arterioles and
increase in glomerular hydrostatic pressure. Although other
vasoactive systems may be relevant, we could find no association
between GFR and the urinary excretion of the vasodilators kallikrein
and prostaglandin E2 or the
vasopressor prostaglandin F1
.
The renal phenotypes found in the present study resemble those observed in the fawn-hooded rat model of hypertension and renal failure.17 50 Before the development of hypertension, these animals show glomerular hyperfiltration.51 Despite the fact that these animals appear to have low plasma renin activity, ACE inhibition52 or angiotensin receptor blockade53 restores renal function and BP to normal.
Functional polymorphisms of the ACE and angiotensinogen genes have been associated with renal abnormalities.54 55 However, we could find no association of GFR and plasma active renin with these ACE and angiotensinogen polymorphisms or those of the renin gene. Our results do not exclude small phenotypic effects of these polymorphisms or the involvement of other polymorphisms of these or other genes.
In summary, the present study reveals extracellular sodium and volume depletion in young adults with high BP. We hypothesize that volume depletion augments sympathetic nerve activation and renin release, which, in combination with familial factors, contribute to glomerular hyperfiltration.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received October 25, 1999; first decision November 19, 1999; accepted November 26, 1999.
| References |
|---|
|
|
|---|
2. Guyton AC, Coleman TG, Cowley AW, Scheel KW, Manning RD, Norman RA. Arterial pressure regulation: over-riding dominance of the kidneys in long-term regulation and in hypertension. Am J Med. 1972;52:584594.[Medline] [Order article via Infotrieve]
3. Tarazi RC. Hemodynamic role of extracellular fluid in hypertension. Circ Res. 1976;38:7383.[Abstract]
4. Dustan HP, Tarazi RC, Bravo EL, Dart RA. Plasma and extracellular fluid volumes in hypertension. Circ Res. 1973;1:7383.
5. Bing RF, Smith AJ. Plasma and interstitial volumes in essential hypertension: relationship to blood pressure. Clin Sci. 1981;61:287293.[Medline] [Order article via Infotrieve]
6. Bauer JH, Brooks CS. Body-fluid composition in normal and hypertensive man. Clin Sci. 1982;62:4349.[Medline] [Order article via Infotrieve]
7.
Grunfeld B, Perelstein E, Simsolo R, Gimenez M, Romero
JC. Renal functional reserve and microalbuminuria in
offspring of hypertensive parents. Hypertension. 1990;15:257261.
8. Bianchi G, Cusi D. Gatti M, Lupi GP, Ferrari P, Barlassina C, Picotti GB, Bracchi G, Colombo G, Gori D, Velis O, Mazzei D. A renal abnormality as a possible cause of essential hypertension. Lancet. 1979;1:173177.[Medline] [Order article via Infotrieve]
9.
Herlitz H, Widgren B, Urbanavicius V, Attvall S,
Persson B. Stimulatory effect of insulin on tubular sodium reabsorption
in normotensive subjects with a positive family history of
hypertension. Nephrol Dial Transplant. 1996;11:4754.
10. Uneda S, Fujishima S, Fujiki Y, Tochikubo O, Oda H, Asahina S, Kaneko Y. Renal haemodynamics and the renin-angiotensin system in adolescents genetically predisposed to essential hypertension. J Hypertens Suppl.. 1984;2:S437S439.[Medline] [Order article via Infotrieve]
11. van Hooft IM, Grobbee DE, Derkx FH, de Leeuw PW, Schalekamp MA, Hofman A. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents. N Engl J Med. 1991;324:13051311.[Abstract]
12. Widgren BR. Family history and pathophysiological mechanisms of primary hypertension: studies in non-hypertensive young men with positive and negative family histories of hypertension. Scand J Urol Nephrol Suppl. 1991;134:175.[Medline] [Order article via Infotrieve]
13. Beretta Piccoli C, Davies DL, Boddy K, Brown JJ, Cumming AM, East BW, Fraser R, Lever AF, Padfield PL, Semple PF, Robertson JI, Weidmann P, Williams ED. Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci. 1982;63:257270.[Medline] [Order article via Infotrieve]
14. Harrap SB, Doyle AE. Genetic co-segregation of renal haemodynamics and blood pressure in the spontaneously hypertensive rat. Clin Sci. 1988;74:6369.[Medline] [Order article via Infotrieve]
15.
Roman RJ, Kaldunski M. Pressure natriuresis and
cortical and papillary blood flow in inbred Dahl rats. Am J
Physiol. 1991;261:R595R602.
16. Salvati P, Pinciroli GP, Bianchi G. Renal function of isolated perfused kidneys from hypertensive (MHS) and normotensive (MNS) rats of the Milan strain at different ages. J Hypertens Suppl.. 1984;2:S351S353.[Medline] [Order article via Infotrieve]
17. de Keijzer MH, Provoost AP, Molenaar JC. Glomerular hyperfiltration in hypertensive fawn-hooded rats. Ren Physiol Biochem. 1988;11:103108.[Medline] [Order article via Infotrieve]
18. Watt GC, Harrap SB, Foy CJ, Holton DW, Edwards HV, Davidson HR, Connor JM, Lever AF, Fraser R. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens. 1992;10:473482.[Medline] [Order article via Infotrieve]
19. Watt G. Design and interpretation of studies comparing individuals with and without a family history of high blood pressure. J Hypertens. 1986;4:17.[Medline] [Order article via Infotrieve]
20. Watt GC, Foy CJ, Holton DW, Edwards HE. Prediction of high blood pressure in young people: the limited usefulness of parental blood pressure data. J Hypertens. 1991;9:5558.[Medline] [Order article via Infotrieve]
21. Rostrup M, Mundal HH, Westheim A, Eide I. Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. J Hypertens. 1991;9:159166.[Medline] [Order article via Infotrieve]
22. Harrap SB, Davies DL, Macnicol AM Dominiczak AF, Fraser R, Wright AF, Watson ML, Briggs JD. Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int. 1991;40:501508.[Medline] [Order article via Infotrieve]
23. Watson ML, Lambie AT, Thom A, Ungar A. Role of prostaglandins in mediating excretion by the kidney of an intravenous infusion of sodium chloride in normal human subjects. Clin Sci. 1982;62:2733.[Medline] [Order article via Infotrieve]
24. Amundsen E, Putter J, Friberger P, Knos M, Larsbraten M, Claeson G. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol. 1979;120A:8395.
25.
Naftilan AJ, Williams R, Burt D, Paul M, Pratt RE,
Hobart P, Chirgwin J, Dzau VJ. A lack of genetic linkage of renin gene
restriction fragment length polymorphisms with human hypertension.
Hypertension. 1989;14:614618.
26.
Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol
P, Fraser R, Foy CJ, Watt GC. The angiotensin I converting
enzyme gene and predisposition to high blood pressure.
Hypertension. 1993;21:455460.
27.
Corvol P, Jeunemaitre X. Molecular genetics of human
hypertension: role of angiotensinogen. Endocr
Rev. 1997;18:662677.
28. Rose G. Strategy of prevention: lessons from cardiovascular disease. BMJ. 1981;282:18471851.
29.
Stamler J, Stamler R, Neaton JD. Blood pressure,
systolic and diastolic, and
cardiovascular risks: US population data. Arch
Intern Med. 1993;153:598615.
30. Ulrych M, Ulrych Z. Significance of increase in labelled albumin disappearance rate in arterial hypertension. Clin Sci Mol Med Suppl. 1976;3:211s213s.[Medline] [Order article via Infotrieve]
31. Tarazi RC, Frohlich ED, Dustan HP. Plasma volume in men with essential hypertension. N Engl J Med. 1968;278:762765.
32. Meade TW, Imeson JD, Gordon D, Peart WS. The epidemiology of plasma renin. Clin Sci. 1983;64:273280.[Medline] [Order article via Infotrieve]
33. Grim CE, Luft FC, Miller JZ, Brown PL, Gannon MA, Weinberger MH. Effects of sodium loading and depletion in normotensive first-degree relatives of essential hypertensives. J Lab Clin Med. 1979;94:764771.[Medline] [Order article via Infotrieve]
34. Gudmundsson O, Andersson OK, Aurell M, Wikstrand JM, Berglund GL. Calf muscle haemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with a familial predisposition to hypertension: changes during increased salt intake. J Hypertens. 1984;2:291296.[Medline] [Order article via Infotrieve]
35. Neutel JM, Smith DH, Graettinger WF, Winer RL, Weber MA. Heredity and hypertension: impact on metabolic characteristics. Am Heart J. 1992;124:435440.[Medline] [Order article via Infotrieve]
36. Shibutani Y, Sakamoto K, Katsuno S, Yoshimoto S, Matsuura T. An epidemiological study of plasma renin activity in schoolchildren in Japan: distribution and its relation with family history of hypertension. J Hypertens. 1988;6:489493.[Medline] [Order article via Infotrieve]
37. Fujishima S, Tochikubo O, Kaneko Y. Environmental and physiological characteristics in adolescents genetically predisposed to hypertension. Jpn Circ J. 1983;47:276282.[Medline] [Order article via Infotrieve]
38. Licata G, Scaglione R, Corrao S, Ganguzza A, Mazzola G, Arnone S, Dichiara MA, Licata A, Merlino G, Di Chiara T. Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens. 1995;13:611618.[Medline] [Order article via Infotrieve]
39.
Textor SC, Turner ST. Renal vascular response to sodium
loading in sons of hypertensive parents. Hypertension. 1991;17:982988.
40.
Herlitz H, Widgren B, Wikstrand J, Aurell M.
Abnormalities in the
renin-angiotensin-aldosterone system in
normotensive subjects with a positive family history of hypertension.
Eur J Endocrinol. 1994;131:179183.
41.
Davis JO, Freeman RH. Mechanisms regulating renin
release. Physiol Rev. 1976;56:156.
42. Esler M, Zweifler A, Randall O, Julius S, DeQuattro V. The determinants of plasma-renin activity in essential hypertension. Ann Intern Med. 1978;88:746752.
43. Esler M, Julius S, Zweifler A, Randall O, Harburg E, Gardiner H, DeQuattro V. Mild high-renin essential hypertension: neurogenic human hypertension? N Engl J Med. 1977;296:405411.[Abstract]
44. Esler MD, Jennings GL, Johns J, Burke F, Little PJ, Leonard P. Estimation of total renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release. J Hypertens Suppl.. 1984;2:S123S125.[Medline] [Order article via Infotrieve]
45.
Harrap SB, Fraser R, Inglis GC, Lever AF, Beastall GH,
Dominiczak MH, Foy CJ, Watt GC. Abnormal epinephrine release in
young adults with high personal and high parental blood pressures.
Circulation. 1997;96:556561.
46. Julius S, Esler M. Increased central blood volume: a possible pathophysiological factor in mild low-renin essential hypertension. Clin Sci Mol Med Suppl. 1976;3:207s210s.[Medline] [Order article via Infotrieve]
47. Schmieder RE, Ruddel H, Schachinger H, Bruns J, Schulte W. Renal hemodynamics and cardiovascular reactivity in the prehypertensive stage. Behav Med. 1993;19:512.[Medline] [Order article via Infotrieve]
48. Stadler P, Pusterla C, Beretta Piccoli C. Renal tubular handling of sodium and familial predisposition to essential hypertension. J Hypertens. 1987;5:727732.[Medline] [Order article via Infotrieve]
49. Kardia SL, Sing CF, Turner ST. The response of renal plasma flow to angiotensin II infusion in a population-based sample and its association with the parental history of essential hypertension. J Hypertens. 1997;15:483493.[Medline] [Order article via Infotrieve]
50. Simons JL, Provoost AP, De Keijzer MH, Anderson S, Rennke HG, Brenner BM. Pathogenesis of glomerular injury in the fawn-hooded rat: effect of unilateral nephrectomy. J Am Soc Nephrol. 1993;4:13621370.[Abstract]
51. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int. 1994;46:396404.[Medline] [Order article via Infotrieve]
52. Magro AM, Rudofsky UH. Plasma renin activity decrease precedes spontaneous focal glomerular sclerosis in aging rats. Nephron. 1982;31:245253.[Medline] [Order article via Infotrieve]
53. Ziai F, Ots M, Provoost AP, Troy JL, Rennke HG, Brenner BM, Mackenzie HS. The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure. Kidney Int Suppl. 1996;57:S132S136.[Medline] [Order article via Infotrieve]
54. Miller JA, Scholey JW, Thai K, Pei YP. Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. Kidney Int. 1997;51:119124.[Medline] [Order article via Infotrieve]
55.
Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH,
Krolewski AS. Diabetic nephropathy is associated with AGT
polymorphism T235: results of a family-based study.
Hypertension. 1998;31:627631.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |